Effective January 1, 2017, payment for infusion drugs furnished through a covered item of DME will be based on Section 1847A of the Social Security Act, meaning that most of the payments will be based on the Average Sales Price of these drugs. The ASP Drug Pricing data for 2017 and subsequent years will no longer contain values for the Infusion AWP or the DME infusion limit. Unless otherwise specified, the Payment Limit will be applied to payments for drugs infused through covered DME. Additional information of DME Infusion Drug Pricing is available through the DME MACs.
Medicare Part B Drug Average Sales Price & Payment Allowance Limits
Effective October 1, 2017 through December 31, 2017
Effective July 1, 2017 through September 30, 2017
Effective April 1, 2017 through June 30, 2017
Effective January 1, 2017 through March 31, 2017
Effective October 1, 2016 through December 31, 2016
Effective October 1, 2017 through December 31, 2017
Effective July 1, 2017 through September 30, 2017
Effective April 1, 2017 through June 30, 2017
Effective January 1, 2017 through March 31, 2017
Effective October 1, 2016 through December 31, 2016
